3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Neuroblastoma
44
Brain Neoplasms
18
Central Nervous System Neoplasms
12
Glioma
11
Medulloblastoma
8
Neoplasms
6
Gliosarcoma
6
Glioblastoma
6
Ganglioneuroblastoma
6
Astrocytoma
6
Sarcoma, Ewing
5
Sarcoma
5
Rhabdomyosarcoma
5
Rhabdoid Tumor
5
Recurrence
5
Meningeal Carcinomatosis
5
Wilms Tumor
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Oligodendroglioma
3
Lymphoma
3
Familial ependymoma
3
Dendritic Cell Sarcoma, Interdigitating
3
Burkitt Lymphoma
3
Testicular Neoplasms
2
Retinoblastoma
2
Ovarian Neoplasms
2
Osteosarcoma
2
Optic Nerve Glioma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neoplasm Metastasis
2
Interventions
ziprasidone
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Topotecan
1
Tobramycin
1
Spironolactone
1
Sevelamer
1
Rocuronium
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Music Therapy
1
Molindone
1
Methylprednisolone
1
Lurasidone Hydrochloride
1
Labetalol
1
Haloperidol
1
Gemcitabine
1
Fosfomycin
1
Dialectical Behavior Therapy
1
Clozapine
1
Ciprofloxacin
1
Cidofovir
1
Cholecalciferol
1
Cefepime
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Meningitis
×
Topotecan
×
CNS
×
Clear all
NCT00674674
2012-05-15
PBTC-019
Baylor College of Medicine
Phase 1
Completed
22 enrolled